Literature DB >> 4884753

[Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis].

F Jerusalem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4884753

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  6 in total

1.  A new agent for the control of spasticity.

Authors:  R F Jones; D Burke; J E Marosszeky; J D Gillies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

2.  Editorial: Control of spasticity.

Authors: 
Journal:  Br Med J       Date:  1973-12-29

3.  Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.

Authors:  D W Hedley; J A Maroun; M L Espir
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

4.  L-glutamate decarboxylase and choline acetyltransferase activity in the substantia nigra and the striatum after surgical interruption of the strio-nigral fibres of the baboon.

Authors:  K Kataoka; I J Bak; R Hassler; J S Kim; A Wagner
Journal:  Exp Brain Res       Date:  1974-01-31       Impact factor: 1.972

Review 5.  Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 6.  Drugs used to treat spasticity.

Authors:  M Kita; D E Goodkin
Journal:  Drugs       Date:  2000-03       Impact factor: 11.431
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.